74.90
-0.10
(-0.13%)
At close: 1:30:38 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,122,099.00
1,085,313.00
1,235,759.00
1,256,341.00
526,351.00
Investing Cash Flow
-176,476.00
-2,633.00
-133,136.00
-168,779.00
147,236.00
Financing Cash Flow
-790,637.00
-816,328.00
-1,103,401.00
-1,044,128.00
-806,608.00
End Cash Position
2,677,780.00
2,621,020.00
2,357,324.00
2,222,253.00
2,223,730.00
Capital Expenditure
-105,144.00
-99,581.00
-135,501.00
-74,154.00
-181,860.00
Issuance of Debt
10,050,000.00
10,680,000.00
11,320,000.00
5,400,000.00
6,120,000.00
Repayment of Debt
-9,944,356.00
-10,628,448.00
-11,644,674.00
-5,420,543.00
-5,909,650.00
Free Cash Flow
1,016,955.00
985,732.00
1,100,258.00
1,182,187.00
344,491.00
12/31/2020 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8432.TWO TSH Biopharm Corporation Limited
57.60
-2.70%
4114.TWO Synmosa Biopharma Corporation
33.20
-2.06%
4123.TWO Center Laboratories, Inc.
41.60
-2.12%
3705.TW YungShin Global Holding Corporation
52.30
-0.57%
1789.TW ScinoPharm Taiwan, Ltd.
22.10
+0.45%
4119.TW SCI Pharmtech, Inc.
84.10
+0.12%
4746.TW Formosa Laboratories, Inc.
71.70
-0.55%
1707.TW Grape King Bio Ltd
145.00
-1.02%
1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
60.80
-1.14%
1795.TW Lotus Pharmaceutical Co., Ltd.
258.00
-2.09%